• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHANG Xiaojiao, ZHANG Hailong, XIANG Youqin, DING Jinsong. Dose dumping of levomilnacipran hydrochloride sustained-release capsules[J]. Journal of China Pharmaceutical University, 2022, 53(1): 60-66. DOI: 10.11665/j.issn.1000-5048.20220109
Citation: ZHANG Xiaojiao, ZHANG Hailong, XIANG Youqin, DING Jinsong. Dose dumping of levomilnacipran hydrochloride sustained-release capsules[J]. Journal of China Pharmaceutical University, 2022, 53(1): 60-66. DOI: 10.11665/j.issn.1000-5048.20220109

Dose dumping of levomilnacipran hydrochloride sustained-release capsules

More Information
  • Received Date: January 31, 2021
  • Revised Date: January 14, 2022
  • In this study, different functional layer formulations and process parameters were used to prepare the levomilnacipran hydrochloride sustained-release capsules, the influence of functional layer formulation and process factors on dose dumping was studied by comparing their release curves in 40% ethanol; and the risk of dose dumping of the self-developed drug was evaluated by the similar factors of the release curve of the self-developed drug and the reference drug.The results showed that as the coating weight increased, the degree of dose dumping decreased; when the concentration of ethanol in the coating liquid solvent was less than 80%, the dose dumping increased; as the atomization pressure and maturation time increase, the dose dumping became more serious. In 0% ethanol (purified water), 5% ethanol, 20% ethanol and 40% ethanol media, the self-developed and reference preparations had the same degree of dose dumping within the specified time, and rotation speed had no significant effect on the release of metformin in vitro. In summary, formulation factors such as coating weight gain, ethanol concentration in the coating solution solvent, and process factors such as atomization pressure and curing time have a serious impact on the dose dumping of sustained-release capsules.Under the optimal functional layer formulation and process, special attention should be paid to the control of risk of self-developed dose dumping.
  • [1]
    .https://fliphtml5.com/zcmg/iwuj.
    [2]
    FDA. Information for healthcare professionals: hydromorphone hydrochloride extended-release capsules(marketed as Palladone)[EB/OL].https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/information-healthcare-professionals-hydromorphone-hydrochloride-extended-release-capsules-marketed#: ~ :text = Information%20for%20Healthcare%20Professionals%3A%20Hydromorphone%20Hydrochloride%20Extended-Release%20Capsules,0.6-3.4%20%20%200.4-1.5%20%20%200.5-1.9%20.
    [3]
    Murray S,Wooltorton E. Alcohol-associated rapid release of a long-acting opioid[J]. CMAJ,2005,173(7): 756.
    [4]
    Darke AC. Controlled-release opioids and alcohol[J]. CMAJ,2006,174(3):352.
    [5]
    Anand O,Yu LX,Conner DP,et al. Dissolution testing for generic drugs:an FDA perspective[J]. AAPS J,2011,13(3):328-335.
    [6]
    PMDA.Regarding concepts on bioequivalence test of production change of oral solid preparation[EB].[2013-04-19].http://www.pmda.go.jp/files/000157176.pdf#page = 16.
    [7]
    FDA.Levomilnacipran[EB/OL].[2013-07-25https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204168s000lbl.pdf
    [8]
    Hair P,Cameron F,Garnock-Jones KP. Levomilnacipran extended release:first global approval[J]. Drugs,2013,73(14):1639-1645.
    [9]
    He S,Yang XM,Li HF. New antidepressant:levomilnacipran[J].Chin J New Drugs Clin Med(中国新药与临床杂志),2015,34(6):418-422.
    [10]
    Surana R,Divi M,Chhettry A. Stable dosage forms of levomilnacipran:
    US8481598[P]. 2013-07-09.
    [11]
    Narisawa S,Yoshino H,Hirakawa Y,et al. Porosity-controlled ethylcellulose film coating. I. formation of porous ethylcellulose film in the casting process and factors affecting film-density[J]. Chem Pharm Bull,1993,41(2):329-334.

Catalog

    Article views (218) PDF downloads (431) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return